Market access is hard. Let’s make it easier.

We’ve been there. We’ve done it. We’ve got the t-shirt. We know how tough market access can be.
We’re here to make it easier. To get to the best insights, you need the best people and the best data. Our pharma experts go above and beyond to uncover the powerful, market-defining insights you need.

We’re experienced

Our team has delivered over 1500 market access consultancy projects and helped support more than 250 launched brands.

We’re global

We have over 40 market access consultants in 3 continents, plus 2,000 payers and KOLs in more than 40 countries.

We have a great team

Our talented multi-lingual team conducts interviews in-house, so you’ll always get transcripts and soundbites.

We combine data + expertise

We expertly combine reliable, high-quality data with decades of experience to bring you the insights you need.

We focus on relationships, not timesheets

We’re business partners, not lawyers – we won’t count the hours or invoice you for trivial tasks.

We over deliver

Unlike larger consultancies, we dig deeper, analyse further and try harder. We work tirelessly to get the job done.

How and when we can help

	EARLY STAGE PRE-CLINICAL (P1)	LATE STAGE P2 AND P3	LAUNCH	POST-LAUNCH
CONSULTING	PAYER AND KEY OPINION LEADERS RESEARCH/AD-BOARDS
	COMPETITIVE INTELLIGENCE (PIPELINE, HTA, EVIDENCE, PRICE DRIVERS)
	PRICE DISCOVERY		PRICE AND LAUNCH STRATEGY	PRICE PROTECTION/IRP ANALYSIS
	EVIDENCE GAP ANALYSIS			HTA TRACKING
	MULTI-INDICATION VALUE ASSESSMENTS			REVENUE OPTIMISATION MODELS
	ANALOGUE ANALYSIS
		LAUNCH SEQUENCE ANALYSIS
	DUE DILIGENCE ASSESSMENTS
		COMPETITIVE WORKSHOPS/SUMMITS

Find out more about our services and products. Download our capabilities deck today and find out why you should add us to your RFP shortlist.

Our global reach

Our consulting services

Our clients love what we do

Access Infinity provided excellent in-depth insights and guidance in key global markets. I’ve been very pleased with their responsiveness and the quality of work

Kevin La Wall Commercial Director, Infectious Diseases, GSK

The analyses was great and very well done! The work was quite robust and thorough given such incredibly short timelines!

Ellison Suthoff Sage Therapeutics, US

Our consulting work in numbers

0 +

Hours of payer & KOL interviews conducted in-house

1000 +

Consulting projects